Odisha to Host Pharma Summit 2025, Unveil New Pharma and Medical Devices Policy
The summit will bring together pharmaceutical and medical devices manufacturers, startups, innovators, healthcare experts, investors, and other industry stakeholders to explore opportunities within Odisha’s growing pharmaceuticals and healthcare manufacturing sector.
Outsourcing | 15/12/2025 | By Darshana | 140
High-Impact HDV Candidate Drives Mirum's 620 Million USD Acquisition of Bluejay
Mirum Pharmaceuticals, Inc., a leading rare disease company, has entered a definitive agreement to acquire Bluejay Therapeutics, a privately held biotechnology firm focused on viral and liver diseases.
Outsourcing | 09/12/2025 | By Darshana
Nadda Urges Pharma Industry to Cut Reliance on Imported APIs
Health Minister Mansukh Mandaviya has called on India’s pharmaceutical industry to reduce dependency on imported active pharmaceutical ingredients (APIs) and focus on strengthening domestic manufacturing capability. He emphasised that enhancing self-reliance in API production is vital for national health security and economic resilience.
Outsourcing | 21/11/2025 | By Darshana
Olympus Corporation, a global medical technology company dedicated to making lives healthier, safer and more fulfilling, has entered into an exclusive worldwide distribution agreement with MacroLux Medical Technology Co., Ltd. to provide a range of single-use urology products, including cystoscopes, ureteroscopes and suction access sheaths.
Outsourcing | 06/09/2025 | By Darshana | 251
Known for its strong capabilities in biotechnology and respiratory therapeutics manufacturing, Shilpa Medicare—through its biologics arm, Shilpa Biologics—will serve as Alveolus Bio’s exclusive global development and manufacturing partner.
Outsourcing | 07/08/2025 | By Darshana | 214
Outsourcing | 17/05/2022 | By Content editor | 1476
Glenmark's subsidiary, Ichnos Sciences signs licensing pact with Almirall
Glenmark's 100% subsidiary Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, and Almirall S.A, a global biopharmaceutical company focused on skin health, announced today that they have entered into an exclusive licensing agreement for the IL-1RAP antagonist ISB 880
Outsourcing | 14/12/2021 | By Darshana | 1472
Natco Pharma's partner Breckenridge Pharma launches generic Afinitor in US market
Natco Pharma Limited announced that its marketing partner Breckenridge Pharmaceutical, Inc., US has launched the 10mg strength of everolimus tablets (generic for Afinitor) in the US market
Outsourcing | 01/10/2021 | By Darshana | 1499
ICMR invites proposals for providing clinical trials liability insurance for SOLIDARITY PLUS trial
ICMR through ICMR-National AIDS Research Institute, Pune is coordinating a trial, titled "An international randomized trial of additional treatments for Covid-19 in hospitalized patients who are all receiving the local standard of care SOLIDARITY TRIAL PLUS" or World Health Organization (WHO)-India (ICMR) SOLIDARITY trial plus
Outsourcing | 27/08/2021 | By Darshana | 1278
The Department of Pharmaceuticals (DoP) has extended the timeline for submission of applications under the production linked incentive scheme for promotion of domestic manufacturing of critical key starting materials (KSMs) or drug intermediates and active pharmaceutical ingredients (API) and medical devices, till August 31, 2021
Outsourcing | 30/07/2021 | By Darshana | 967
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy